AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Enzyme inhibitor enhances the work of breast cancer adjuvant endocrine therapy.
2004 JUN 3 - (NewsRx.com & NewsRx.net) -- Enzyme inhibitor enhances the work of breast cancer adjuvant endocrine therapy.
According to a study from England, "the tissue inhibitors of metalloproteinases (TIMPs) control the activities of matrix metalloproteinases (MMPs) and as such, they have been recognized as potential suppressors of angiogenesis and tumor invasion and metastasis.
"However, TIMP-3 has several unique properties that set it apart from other TIMPs, including its ability to bind to extracellular matrix, inhibit related adamalysin metalloproteinases (ADAMs), and induce apoptosis," explained D.R. Edwards and colleagues, University of East Anglia, School of Biological Science.
"New data suggest that high levels of TIMP-3 mRNAs in human breast tumors are associated with success of adjuvant endocrine ...
- More research needed on adjuvant endocrine therapy of breast cancer.
- Newspaper article from: Cancer Weekly June 1, 2004 700+ words
...knowledge of adjuvant and neoadjuvant endocrine therapy of breast cancer. "Adjuvant endocrine therapy following surgical resection of...pertinent to adjuvant or neoadjuvant endocrine therapy for breast cancer," researchers in Scotland report...
- Enzyme inhibitor enhances the work of breast cancer adjuvant endocrine therapy.
- Newspaper article from: Angiogenesis Weekly June 4, 2004 700+ words
...enhances the work of breast cancer adjuvant endocrine therapy. According to a study...success of adjuvant endocrine therapy, but not chemotherapy...Pathology (TIMP-3 and endocrine therapy of breast cancer: an apoptosis connection...
- New model predicts relapse in early breast cancer patients following endocrine...
- Magazine article from: Women's Health Weekly October 9, 2008 700+ words
...relapse in women with stage 2 or 3 breast cancer who have been treated with endocrine therapy prior to surgical removal of the...estrogen receptor (ER)-positive breast cancer with endocrine therapy, such as tamoxifen or letrozole...
- Bcl-2 prognostic factor for breast cancer with chemo- and endocrine therapy.
- Magazine article from: Women's Health Weekly February 20, 2003 700+ words
...factor for breast cancer with chemotherapy and endocrine therapy," the researchers...factor for breast cancer with chemotherapy and endocrine therapy." Yang...invasive breast cancer receiving chemotherapy and endocrine therapy. Oncol Rep...
- Recent advances in endocrine therapy of breast cancer. (review article)
- Magazine article from: British Medical Journal Howell, Anthony Dowsett, Mitchell October 4, 1997 700+ words
...Regression of advanced breast cancer as a result of endocrine therapy was first described...after surgery for breast cancer was shown to...future trends in endocrine therapy and summarise...endocrine therapies Breast cancer cells that are...
- Overview of neoadjuvant endocrine therapy for breast cancer published.
- Magazine article from: Women's Health Weekly June 24, 2004 700+ words
...neoadjuvant endocrine therapy for breast cancer in a recent...benefits of endocrine therapy for patients...sensitive breast cancer remain established...Neoadjuvant endocrine therapy for breast cancer: an overview...
- Randomized trial examines second-line endocrine therapy in advanced breast...
- Newspaper article from: Health & Medicine Week January 5, 2004 700+ words
...day) as endocrine therapy in postmenopausal...advanced breast cancer previously...advanced breast cancer is more responsive...second-line endocrine therapy," the researchers...second-line endocrine therapy in advanced breast cancer: ...
- Aromatase inhibitors constitute new endocrine therapy for breast cancer.
- Newspaper article from: Biotech Week June 9, 2004 700+ words
...inhibitors constitute a new endocrine therapy for breast cancer. "Estrogens are involved...in estrogen-dependent breast cancer," researchers in the United...efficacy for the treatment of breast cancer. The initial nonselective...
- HOXB13/IL17BR Ratio (H/I(TM) Ratio) Predicts Clinical Benefit for Prolonged...
- Press release article from: PR Newswire May 3, 2007 700+ words
...early stage breast cancer patients were...five years of endocrine therapy. The investigators...274,000 new breast cancer cases annually...the annual breast cancer death by about...of adjuvant endocrine therapy with tamoxifen...
- Fluoxymesterone as third-line endocrine therapy for advanced breast cancer: a...
- Newspaper article from: Cancer Weekly June 29, 1992 700+ words
...patients with advanced breast cancer respond to hormonal...treatment of advanced breast cancer, but once patients...responded to prior endocrine therapy, one had a partial...patients with advanced breast cancer who had uniform prior...
Source: HighBeam Research, Enzyme inhibitor enhances the work of breast cancer adjuvant...